Table 1:
Clinical and demographic characteristics of the patient population
| Demographic and Clinical Parameters | Value |
|---|---|
| Age | |
| Median (yrs) | 52 |
| Range (yrs) | 11–76 |
| Sex | |
| Male | 12 |
| Female | 8 |
| Associated conditions | |
| HBP | 7 |
| DM | 3 |
| Hypercholesterolemia | 4 |
| CAD | 1 |
| Hypothyroidism | 1 |
| BA | 1 |
| BPH | 1 |
| Medications | |
| Calcium channel blockers | 3 |
| ACE | 4 |
| β-blockers | 2 |
| α-Agonists | 1 |
| AEDs | |
| Dilantin (phenytoin) | 3 |
| Tegretol (carbamazepine) | 1 |
| Levetiracetam | 3 |
| Valproic acid | 1 |
| Lamotrigine | 1 |
| Synthroid (levothyroxine) | 1 |
| Statins | 4 |
| Other psychiatric/neurologic | 4 |
| Clinical presentation | |
| Headaches | 9 |
| Seizures | 4 |
| TIAs | 1 |
| Paresthesias | 2 |
| ICH, SAH, IVH | 4 |
| Dizziness | 4 |
| Hemianopsia | 1 |
| Incidental | 3 |
| Pre-embolization neurologic deficits | |
| Blindness | 1 |
| Dysarthria | 1 |
| Nystagmus | 1 |
| Paresis | 1 |
| Dysesthesias | 1 |
| Hemianopsia | 1 |